RESUMO
With an improvement in the long-term survival rates of cancer patients, the requirements for fertility protection of young cancer patients after chemotherapy are increasingly prominent. Early studies have shown that gonadotropin-releasing hormone agonist (GnRHa) has a protective effect on fertility. But in recenct year, relevant studies have shown that its protective effect is controversial. This article reviews the clinical researches of GnRHa for fertility protection in patients with common tumors, and explores its evidence-based medicine, in the hope of providing references for reasonable clinical application.
RESUMO
Objective To explore how clinical pharmacists participate in clinical drug practice.Methods Clinical pharmacists involved in the treatment of one lymphocytic hyophysitis case with glucocorticoid and provided patient with medication education to ensure the safe and effective treatment.Results Pharmacists offered an effective and feasible treatment program for doctors and the patient.Conclusion Clinical pharmacists participated actively in the clinical treatment programs to ensure the effective development of clinical diagnosis and treatment and improve the medication therapy results.